orangecat, there is no way this company has earnings of $1B over the next 3-4 years. I have been here as long as anyone else. I share the sentiment of ssmmss. Dr Chan needs to step down and let someone focus on the share price and their shareholders.
It's great that Germany is progressing. However, I never hear anything about any other country. If you look at the Registry, the only country that is growing is Germany. I asked Dr. Chan a while ago how our sales force is progressing in other countries. I see no movement or growth on the Registry. Why are they not growing? Why can't we expand our sales team? How long does it take, on average, to get into a hospital and get buy-in from them? What is the process? How many sales people do we have dedicated to each country? This is why things take so long. The focus is Germany. It will take years and years to grow these other countries without an extensive sales force.
I know we have Fresenius and Terumo. I'm just waiting for something to pop with them. It's been too many years for Fresenius. Why aren't they making more of a move with CTSO??? Hoping these 2 companies can expedite our growth. we certainly can't go at it along. And where is Biocon? Holy cow! Everyone was so excited to have them on board. they have been a complete flop.
I think Zack's estimates are pretty on target right now unless one of these companies strikes a deal with us. I think Q1 will be at $3M...nothing more. This is nice growth but not where we need to be at this stage of the company's life.
Oh, and where is Canada in this process? Why can't we get an update from them? Even if we get approval from Canada tomorrow, revenue won't take off for years. Back to my questions to DC above. How long does it take, on average, to get into hospitals, run through training, and begin ramping up revenue? I'm thinking somewhere around 8-12 months. Look at how long they have been in Germany? They just hit their first $1M hospital. I want to know how long they have been working with this hospital.
This stock has no following. Why???? I agree with a lot that DC needs to bring in someone with a better sense on how to grow the stock price and earnings. We stumbled big time about 3 years ago with this product. Our sales should be a lot higher than they are right now. I attribute this to a lack of planning and insight from management. The fact that we are at $10M right now is ridiculous. If things would have gone right, we should be at $30M-$40M easily right now. Zack's estimate doesn't get us there until 2020.
There are a lot of questions to be answered by DC. I have more than a fortune tied up in this company. DC refuses to answer a lot of my questions. My next step is the Board. After that, I will be asking for support from the shareholders. Maybe collectively, we can get this company back on track.
News 
Market Data 
Discover 
AI
